Anavex Life Sciences Corp (AVXL)

[Gernee20]

Could it be that this “soup” has new learned data that has new endpoints which are being designed by the company and the Fda in these 4 new trials.

I suspect the foundation researchers are eager to see Avatar data as well, perhaps to confirm endpoints but simply to confirm their commitment and potential funding from their respective organization(s). These will be large investments from the foundations. Additionally, Missling previously said they are not disclosing the new indication because they were deciding between multiple potential indications. I think the Avatar data delay is the reason for the new trial delays, either because anavex needs the data to proceed, or possibly because the foundations need the data to be 100% committed.

Avatar data that isnt so great could mean different indications flip flop in a ranking of trial priority - which could be determined by Anavex, the foundations, or likely both. If Avatar readout is good/great, I would suspect the undisclosed indication turns into indications - plural.